These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3390960)

  • 21. Plasma immunoreactive endothelin in essential hypertension.
    Kohno M; Yasunari K; Murakawa K; Yokokawa K; Horio T; Fukui T; Takeda T
    Am J Med; 1990 Jun; 88(6):614-8. PubMed ID: 2189304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contents of dopamine sulfoconjugate isomers and their desulfation in dog arteries.
    Hashizume K; Yamatodani A; Yamamoto T; Wada H; Ogihara T
    Biochem Pharmacol; 1989 Jun; 38(12):1891-5. PubMed ID: 2742597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increase in urinary catecholamines of renal origin in patients with "borderline" hypertension.
    Kuchel O; Cuche JL; Buu NT; Genest J
    Am J Med Sci; 1976; 272(3):263-8. PubMed ID: 1015511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited.
    Kuchel O; Buu NT; Larochelle P; Hamet P; Genest J
    Arch Intern Med; 1986 Jul; 146(7):1315-20. PubMed ID: 3718127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
    Kuchel O
    Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic abnormalities in borderline essential hypertensive patients.
    Shigetomi S; Buu NT; Kuchel O
    Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease.
    Zoccali C; Leonardis D; Parlongo S; Mallamaci F; Postorino M
    Nephrol Dial Transplant; 1995; 10(8):1320-3. PubMed ID: 8538921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamine clearance is not enhanced by increasing levels within the physiological range.
    Gordon RD; Bachmann AW; Mikulecky M; Gueizelar BT
    Clin Exp Hypertens A; 1989; 11 Suppl 1():337-43. PubMed ID: 2743595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma norepinephrine and epinephrine levels in essential hypertension.
    Goldstein DS; Lake CR
    Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of high sodium diet on dopaminergic mechanism in normal and hypertensive subjects].
    Takahashi M; Miura Y; Sano N; Ohzeki T; Sugawara T; Noshiro T; Meguro Y; Watanabe H; Shimizu K; Hanew K
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov; 64(11):1157-68. PubMed ID: 3065095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
    Kuchel OG; Shigetomi S
    Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased peripheral dopaminergic activity in essential hypertension?
    Kjeldsen SE; Flaaten B; Eide I; Helgeland A; Leren P; Fønstelien E
    Scand J Clin Lab Invest; 1983 Feb; 43(1):15-20. PubMed ID: 6622964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of dopamine-3- and 4-O-sulphate in human plasma and urine by anion-exchange high-performance liquid chromatography with fluorimetric detection.
    Yamamoto T; Yamatodani A; Nishimura M; Wada H
    J Chromatogr; 1985 Aug; 342(2):261-7. PubMed ID: 4055948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension--clinical and experimental studies.
    Yoshizumi M; Kitagawa T; Hori T; Katoh I; Houchi H; Ohuchi T; Oka M
    Life Sci; 1996; 59(4):324-30. PubMed ID: 8761004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of noradrenaline and dopamine in patients with essential hypertension or with pheochromocytoma.
    Yoshimura M; Ikegaki I; Fukuyama M; Nishimura M; Takahashi H
    Clin Exp Hypertens A; 1989; 11 Suppl 1():397-402. PubMed ID: 2743600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma adrenaline, noradrenaline and dopamine in pregnancy hypertension.
    Davey DA; Macnab MF
    Br J Obstet Gynaecol; 1981 Jun; 88(6):611-8. PubMed ID: 7248219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between plasma catecholamines and urinary catecholamine excretion rates in normal subjects and certain diseased states.
    Schiffl H; Weidmann P; Meier A; Ziegler WH
    Klin Wochenschr; 1981 Aug; 59(15):837-44. PubMed ID: 7021996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure.
    Fukuda S; Kobayashi H; Mochizuki T; Tanaka M; Yokoyama Y; Hattori N
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1011-7. PubMed ID: 1479729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated concentrations of dopamine sulfate in plasma of cocaine abusers.
    Faraj BA; Camp VM; Davis DC; Kutner M; Cotsonis GA; Holloway T
    Biochem Pharmacol; 1993 Oct; 46(8):1453-7. PubMed ID: 8240395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.